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INTRODUCTION:  Undifferentiated  head  of pancreas  carcinoma  with  osteoclast-like  giant cells  (UC-OGC)
is a rare  neoplasm,  with  less  than  a hundred  cases  reported.  We  present  such  a case,  in  which  the  UC-OGC
presented  atypically  as  a cystic  lesion  following  acute  pancreatitis  and  led to late diagnosis.
PRESENTATION  OF  CASE:  A 75-year-old  female  patient,  who  had  suffered  acute  pancreatitis  three  years  ago,
was referred  with  a diagnosis  of osteoclast-like  giant  cell  (OGC)  tumor  of the  head  of pancreas.  She  had
suffered  acute pancreatitis  three  years  ago. Two  years  ago  she  developed  abdominal  pain,  steatorrhea  and
weight loss.  Abdominal  computed  tomography  imaging  showed  a cystic  mass  in the head  of the  pancreas
(maximum  diameter  4 cm).  The  initial  diagnosis  was  pancreatic  pseudocyst;  however  as  the  mass  grad-
ually  increased  in size  and  the  patient  continued  to  be symptomatic,  a CT-guided  biopsy  was  performed.
Histological  examination  revealed  an OGC pancreatic  tumor.  In laparotomy  a  large  (9 cm)  encapsulated
heterogeneous  mass  was  found  with  partial  involvement  of the  common  hepatic  artery.  Pancreatico-
duodenectomy  was  performed  and  the  involved  part of the  common  hepatic  artery  was  replaced  with
a homologous  graft from  the  major  saphenous  vein.  Post-operative  course  was  uneventful.  Histology
revealed  an  undifferentiated  pancreatic  adenocarcinoma  with  OGCs.  She  survived  10 months  after  the
operation.
DISCUSSION:  Pancreatic  undifferentiated  carcinomas  with  OGCs  are  very  rare  neoplasms  and  can  present
with an  atypical  clinical  picture.
CONCLUSIONS:  A  symptomatic  cystic  lesion  of the  pancreas,  which  is  growing  in size, should  be investi-
gated  promptly  in order  to  exclude  the  presence  of malignancy.
Publi
he CC©  2015  The  Authors.  
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. Introduction
Undifferentiated carcinomas of the pancreas are very rare, non-
ndocrine pancreatic neoplasms of high malignancy. Despite their
istological differences, the current WHO  classiﬁcation places these
umors in a single category under the name of ‘undifferentiated car-
inoma of the pancreas’ [1]. The presence of osteoclast-like giant
ells (OGCs), which is suggested to be non-neoplastic reaction,
Abbreviations: OGCs, osteoclast-like giant cells; UC-OGCs, undifferentiated car-
inomas of the pancreas with OGCs; UC-PGCs, undifferentiated carcinomas of the
ancreas with pleomorphic/sarcomatoid giant cells; WHO, World Health Organi-
ation; CT, computed tomography; MRI, magnetic resonance imaging; TBL, total
ilirubin; ALP, alkaline phosphatase; -GT, gamma glutamyltranspeptidase; CEA,
arcinoembryonic antigen; CA 19-9, cancer antigen 19-9; FNA, ﬁne needle aspira-
ion.
∗ Corresponding author. Fax: +30 2651074001.
E-mail address: georgmd7@gmail.com (G.K. Georgiou).
ttp://dx.doi.org/10.1016/j.ijscr.2015.12.023
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/).shed  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
distinguishes these carcinomas from the plain undifferentiated car-
cinomas. Prognosis is poor with most patients surviving less than
a year, as a result of late diagnosis and tumor aggressiveness [2].
We  present a case of undifferentiated head of pancreas carci-
noma with OGCs of a very unusual clinical presentation, that of a
symptomatic cystic lesion following acute pancreatitis.
2. Presentation of case
The work has been reported in line with the CARE criteria [3].
A 75-year-old female patient with a medical history of hyperten-
sion was  referred to our unit with the diagnosis of a giant cell tumor
at the head of pancreas. Three years ago she presented to her local
hospital with acute idiopathic pancreatitis. Receiving conservative
treatment, she was  asymptomatic for the subsequent 12 months,
before she started suffering from abdominal discomfort, steator-
rhea and weight loss. Computed tomography (CT) abdominal scan
and magnetic resonance imaging (MRI) showed a cystic mass (max.
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Abdominal computed tomography scan showing a 9 cm large head of pan-
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Oreas mass, with solid and cystic components, in close relation to the mesenteric
essels and the common hepatic artery, but with no clear evidence of vascular
nvasion. The pancreatic duct is dilated and the rest of the pancreas is atrophic.
iameter 4 cm)  in the head of pancreas, which was thought to be
 pancreatic pseudo-cyst, but due to increasing size and ensuing
f symptoms, a CT-guided biopsy was performed. Histopathology
howed the presence of multinuclear OGCs and she was  referred to
ur center.
Our CT scan showed a 9 cm large head of pancreas mass, with
olid and cystic components, in close relation (but no invasion) to
he mesenteric vessels and the common hepatic artery (Fig. 1). The
ain pancreatic (but not the common bile duct) was dilated; the
ody and tail of pancreas were atrophic with no evidence of acute
nﬂammation or lymphadenopathy. Chest CT scan was normal. Pre-
perative blood tests (TBL, ALP, -GT, CEA) were normal, except for
A 19-9 at 110 U/ml (normal values: 0–37).
At theater a large encapsulated mass was discovered, in direct
ontact with the common hepatic artery and with the superior
esenteric vein. During dissection of the tumor from the common
epatic artery, it was realized that the common hepatic artery was
nvaded by the tumor. Although it was not clear if a resection would
e beneﬁcial for the patient it was decided the resection to go ahead
s the common hepatic artery was partially injured during the dis-
ection and a reconstruction was needed. For this reason a Whipple
rocedure was performed with excision of the involved part of the
ommon hepatic artery and blood ﬂow was restored with a 3 cm
ong venous graft from the left major saphenous vein. Postoperative
ourse was uneventful. The patient denied having chemotherapy.
ollow-up at 3 and 6 months found her in good health, but unfor-
unately she developed local recurrence and died 10 months after
urgery.
Pathology revealed a round, circumscribed neoplastic mass
easuring 8.5 cm in maximum dimension, extending to the
mpulla of Vater. Microscopic examination showed a malignant
eoplasm composed of undifferentiated cells with great pleomor-
hism and nuclear atypia, as well as of scattered OGCs (Fig. 2).
oreover, a minor well-differentiated adenocarcinoma component
as also seen. Immunohistochemically, the great majority of undif-
erentiated neoplastic cells expressed vimentin and at least some of
hem were stained for cytokeratin and p53. OGCs reacted strongly
or CD68, KP1 and PGM1, and were negative for all other mark-
rs. None of the seven peripancreatic lymph nodes found showed
vidence of metastatic disease.. Discussion
Undifferentiated carcinomas of the pancreas with OGCs (UC-
GCs) are very rare, representing less than 1% of all pancreaticFig. 2. Tumor histology: undifferentiated cells with great pleomorphism and
nuclear atypia, as well as of scattered osteoclast-like giant cells (black arrow).
malignancies [4–6]. They were ﬁrst described by Rosai [7] and
are characterized by the presence of undifferentiated, pleomor-
phic, mononuclear cells and multinucleated OGCs [4]. ‘Pancreatic
osteoclast-like giant cell tumors’ is a term widely used to refer to
these neoplasms, however a more appropriate one would be UC-
OGCs, which describes better their biological behavior [1]. Most of
them are located in the body or tail of the pancreas and usually have
atypical clinical presentation [8]. Nodal involvement is uncommon
and metastases are slow, however most tumors invade adjacent
structures [2,8]. Only few cases report early diagnosis with tumor
diameter less than 3 cm [9,10]. Imaging techniques may identify a
large cystic mass with hemorrhage and necrosis, which sometimes
may  be mistaken for pancreatic pseudocyst, as in our case.
Patients with anaplastic (undifferentiated) pancreatic cancers
live less than those with pancreatic ductal adenocarcinoma [11,12].
UC-OGCs generally have an overall poor prognosis; median sur-
vival is 11 months, dropping to 6.5 months in cases of non-operable
tumors [2,4,8]. However, the interval between diagnosis and death
may  vary signiﬁcantly (from 4 months to 10 years) [13,14]. In the
review by Kobayashi et al. some favorable prognostic factors were
identiﬁed: younger age at time of diagnosis, female gender, smaller
lesions and absence of lymph node involvement [13]. UC-OGCs
seem to have a clearly better outcome than tumors with pleomor-
phic/sarcomatoid giant cells (UC-PGCs) or other variables [11,12].
However, there is still controversy regarding the prognosis of UC-
OGCs when compared to ductal adenocarcinoma [6,11,15].
Histogenesis of UC-OGCs is another issue of controversy. Stud-
ies on light and electron microscopy, on immunophenotype of the
tumor cells and molecular biology analysis, have been used to sup-
port a mesenchymal or an epithelial origin of the tumor [16,17].
Some authors contributed the idea that it arises from a precursor
pluripotent cell that may  differentiate to distinctive phenotypes
[2,16], while others consider it carcinosarcoma-like neoplasm that
consists of both epithelial and histiocytic-mesenchymal compo-
nent [7,17]. Acinar cell origin or derivation from a mucinous cystic
neoplasm or from ductal cells have also been discussed [4,5].
Adequate sampling of the neoplasm will reveal at least a minor
component of atypical neoplastic glands [10]. Furthermore, in some
cases it has been shown that OGCs tumor co-exists with pancre-
atic intraepithelial neoplasia (PanIN 2 and 3) [4,10]. These ﬁndings
strongly support a possible epithelial origin of the neoplasm. How-
ever, the main question remains, whether the undifferentiated
mononuclear cells and the OGCs are of non-neoplastic mesenchy-
mal, neoplastic mesenchymal or epithelial origin.
The role of adjuvant treatment, either chemotherapy or radio-
therapy, has not yet been clearly established, in part due to the
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arity of this pathological entity. There are reports on the use of
hemotherapeutic agents (such as cis-platin, paclitaxel and gemc-
tabine) with favorable outcome, given the epithelial origin of the
umor [9,18,19]. On the other hand, radiotherapy has been applied
n the basis of radiosensitivity of giant-cell tumors of the bones [4]
r as a means of eliminating any remnant cancer cells in the tumor
ed after positive-margin excision [15], sometimes with satisfac-
ory results [20]. However, due to the limited experience in the
reatment of such neoplasms, no safe conclusions can be drawn
21].
In our patient, the characteristic morphology of the tumor, its
o-existence with a small area of well differentiated pancreatic
denocarcinoma, as well as the immunophenotype of both undif-
erentiated pleomorphic cells and OGCs, support the diagnosis of
 UC-OGCs. The unique characteristics in our case is the history of
cute pancreatitis 3 years earlier which was misleading, the pres-
nce of the symptomatic cystic lesion post-pancreatitis which was
iss-interpreted as pancreatic pseudo-cyst and the evidence of
hronic pancreatitis in serial CT with severe parenchymal atrophy
nd dilation of the main pancreatic duct. This ﬁnding of chronic
ancreatitis has not been reported before. It could be attributed to
umor pressure effects.
. Conclusion
These rare pancreatic tumors present with atypical symptoms,
an mimic  a pseudocyst and usually are diagnosed in late stage with
oor prognosis. A high index of suspicion is required in order the
rognosis to be improved. The learning point from our study is that
hen a symptomatic pancreatic cystic lesion, which is increasing
n size, is seen on follow up scans then we should proceed to further
nvestigation of the lesion, preferably with endoscopic ultrasound
nd FNA. This will lead to early diagnosis and effective treatment
n case of malignancy.
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